Qingdao Haier Biomedical Co (SHSE:688139) Market Cap: ¥8,919 Mil (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688139 Qingdao Haier Biomedical Co Ltd SHSE:688139
82 GF Score
Price ¥28.18
GF Value ¥36.05
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Qingdao Haier Biomedical Co Market Cap?

Qingdao Haier Biomedical Co SHSE:688139 +1.04% 82 Market Cap is ¥8,919 Mil as of Jul. 30, 2026. GuruFocus rates SHSE:688139 with a GF Score™ of 82/100 and a GF Value™ of ¥36.05 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 862 Medical Devices & Instruments companies, Qingdao Haier Biomedical Co ranks better than 82.83% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Qingdao Haier Biomedical Co's share price for the quarter that ended in Mar. 2026 was ¥31.21. Qingdao Haier Biomedical Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 316 Mil. Therefore, Qingdao Haier Biomedical Co's market cap for the quarter that ended in Mar. 2026 was ¥9,878 Mil.

Qingdao Haier Biomedical Co's quarterly market cap declined from Sep. 2025 (¥10,378 Mil) to Dec. 2025 (¥10,105 Mil) and declined from Dec. 2025 (¥10,105 Mil) to Mar. 2026 (¥9,878 Mil).

Qingdao Haier Biomedical Co's annual market cap declined from Dec. 2023 (¥12,883 Mil) to Dec. 2024 (¥11,192 Mil) and declined from Dec. 2024 (¥11,192 Mil) to Dec. 2025 (¥10,105 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Qingdao Haier Biomedical Co's Enterprise Value for Today is ¥7,508 Mil.


Qingdao Haier Biomedical Co  (SHSE:688139) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Qingdao Haier Biomedical Co Market Cap Related Terms


Qingdao Haier Biomedical Co Market Cap Historical Data

* Premium members only.

The historical data trend for Qingdao Haier Biomedical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qingdao Haier Biomedical Co Market Cap Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28,796.48 20,126.42 12,883.46 11,191.95 10,104.55

Qingdao Haier Biomedical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,994.81 9,821.57 10,377.99 10,104.55 9,877.75

SHSE:688139 vs ABT, SYK, MDT: Market Cap Comparison

For the Medical Devices subindustry, Qingdao Haier Biomedical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao Haier Biomedical Co Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qingdao Haier Biomedical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Qingdao Haier Biomedical Co's Market Cap falls into.


SHSE:688139
82GF Score
Qingdao Haier Biomedical Co Ltd SHSE:688139
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qingdao Haier Biomedical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Qingdao Haier Biomedical Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=¥31.78*317.953
=¥10,105

Qingdao Haier Biomedical Co's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=¥31.21*316.493
=¥9,878

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of ¥8,919 Mil mean?
Qingdao Haier Biomedical Co (SHSE:688139) has a Market Cap of ¥8,919 Mil as of Jul. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Qingdao Haier Biomedical Co and its competitors. According to the industry distribution chart, Qingdao Haier Biomedical Co ranks #148 out of 862 companies in the Medical Devices & Instruments industry, placing it in the top 17.2%.
Is Qingdao Haier Biomedical Co's Market Cap too high?
Qingdao Haier Biomedical Co's current Market Cap is ¥8,919 Mil. Based on the distribution chart, Qingdao Haier Biomedical Co ranks #148 out of 862 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Qingdao Haier Biomedical Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Haier Biomedical Co's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qingdao Haier Biomedical Co ranks #148 out of 862 companies for Market Cap. This places Qingdao Haier Biomedical Co in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 109.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 109.80, based on 862 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Qingdao Haier Biomedical Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 109.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qingdao Haier Biomedical Co's current Market Cap is ¥8,919 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Haier Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Haier Biomedical Co (SHSE:688139) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥36.05, compared to a current price of ¥28.18 — trading 21.8% below its estimated fair value. The current Market Cap is ¥8,919 Mil. Qingdao Haier Biomedical Co's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Qingdao Haier Biomedical Co (SHSE:688139), the current Market Cap is ¥8,919 Mil as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qingdao Haier Biomedical Co (SHSE:688139) Overvalued in 2026?

Based on GuruFocus' analysis, Qingdao Haier Biomedical Co stock appears to be undervalued. The current stock price of ¥28.18 is trading 21.8% below its estimated GF Value™ of ¥36.05. GuruFocus considers Qingdao Haier Biomedical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688139:

  • Market Cap: ¥8,919 Mil
  • GF Value™: ¥36.05 vs. price of ¥28.18 (21.8% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688139 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Qingdao Haier Biomedical Co Business Description

Address No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
82GF Score

Get the complete analysis for SHSE:688139

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.18
Price
¥36.05
GF Value